Professional Documents
Culture Documents
System and Disease III Comprehensive
System and Disease III Comprehensive
System and Disease III Comprehensive
Anatomy
- Primitive heart tube
o Truncus arteriosus -> aorta, pulmonary trunk
o Bulbis cordis -> smooth part of ventricles
o Primitive ventricle -> rough part (trabeculae carnae) of ventricles
o Primitive atrium -> trabeculated part of atria
o Sinus venosus -> smooth part of ventricles, coronary sinus
- Fetal circulation = oxygenated blood from placenta reaches fetus via 1 umbilical vein,
drained back to placenta via 2 umbilical arteries
o Blood circumvents pulmonary circulation via foramen ovale & ductus arteriosus
- Pericardium = outer fibrous (parietal) pericardium and inner visceral epicardium with a
pericardial space
o Pericarditis = inflammation of pericardium (viral, bacterial, Dressler’s)
o Cardiac tamponade = pericardial effusion -> Beck’s triad (distended neck veins,
hypotension, muffle heart sounds)
o Pericardiocentesis = left subxiphoid (15o) or 5/6th left ICS (45o)
- Heart chambers
o Right atrium = crista terminalis (SA node), pectinate muscle, triangle of Koch (AV
node)
o Right ventricle = rough trabeculae carnae, 3 papillary muscles, tricuspid +
pulmonary valves, moderator band (right bundle branch)
o Left atrium = base of heart, pectinate muscle
o Left ventricle = rough trabeculae carnae, 2 papillary muscles, mitral + aortic valve
- Coronary circulation
o RCA = right atrium/ventricle, SA/AV nodes, pos. 1/3 of interventricular septum
▪ Dominance determined by vessel that gives off PDA -> usually RCA
o LCA = left atrium/ventricle, anterior 2/3 of interventricular septum
▪ Gives off LAD and circumflex
o Cardiac sinus = drains great/middle/small cardiac veins into right atrium
▪ Anterior cardiac veins drain directly into right atrium
- Auscultatory areas
o Aortic (R 2nd ICS), pulmonic (L 2nd ICS), tricuspid (L 3/4th ICS), mitral (L 5th ICS)
o 1st heart sound (lub) = tricuspid/mitral closure, 2nd heart sound (dub) =
aortic/pulmonary closure
- Conduction pathway = SA node -> AV node -> bundle of HIS -> Purkinje fibres
Physiology
Cardiac muscle
- Contraction relaxation = depolarization -> Ca influx (L-type channels) -> release of Ca
from SR (ryanodine receptors) -> Ca binds troponin -> muscle contraction -> Ca pumped
back into SR (SERCA) + out of cell (Na/Ca exchanger, CaATPase) -> relaxation
o Strength of contraction proportional to intracellular [Ca]
o Longer AP due to increased Ca and low K conductance (plateau phase)
- Conduction = SA node -> atrial contraction -> AV node (slow conduction) -> bundle of His
-> Purkinje fibres (fast conduction) -> ventricular contraction
o Works as a syncytium via gap junctions and T-tubules for rapid conduction
o Nodal AP = funny pacemaker current (spontaneous depolarization) due to slow
Na influx, AP due to Ca influx
▪ Nodal tissue has long refractory period
- ANS control
o Sympathetic = Gs adrenergic receptor -> increases cAMP -> increased gap
junctions + Na channel stimulation + increased Ca influx and storage -> positive
ionotropy, dromotropy, chronotropy -> shortens refractory period
o Parasympathetic = Gi muscaranic receptor -> decreases cAMP -> negative
ionotropy (atria), dromotropy, chronotropy -> increases refractory period
- Cardiac cycle
o Systole = AV valves close -> isovolumetric contraction -> increase in ventricular
pressure -> semilunar valves open -> ejection
▪ Afterload = pressure the heart works against = aortic pressure
● Afterload is directly related to ventricular size and pressure,
inversely related to ventricular wall thickness
o Diastole = semilunar vales close -> isovolumetric relaxation -> AV valves open ->
ventricular filling
▪ Preload = initial stretching due to ventricle filling = end diastolic volume
● Frank-Starling mechanism = increased preload -> increase muscle
stretch -> increase the force of contraction -> increase CO
● Sympathetic stimulation -> increased ionotropy -> increased
contractility -> decreased end systolic volume -> increased CO ->
ESPVR slope increases and Frank-Starling curve shifts upwards
- Jugular venous pressure = measurement taken to determine right atrial pressure
o Elevated in right ventricular failure, tricuspid regurgitation, SVC obstruction,
constrictive pericarditis, volume overload
- Heart sounds
o S1 = closure of AV valves
o S2 = closure of semilunar valves
o S3 = oscillation of blood in ventricles -> early diastolic ventricular gallop
o S4 = forceful ejection into stiff ventricle -> late diastolic atrial gallop
- Cardiac output = HR x SV = ∆P / R = MAP / TPR
o CO depends on exercise, age, size, Frank-Starling mechanism, SA node stretching,
venous return, Bainbridge reflex (atrial stretch), tissue metabolism
o TPR = MAP – CVP -> CVP usually = 0
o Fick principle -> CO = lung O2 / arteriovenous O2 difference
o Increase in venous return increases CO
o Increase in venous return increases CO
- Venous return = peripheral venous pressure – central venous pressure / vein resistance
o Lung expansion -> decreased right atrial pressure + increased abdominal venous
pressure -> increased venous return -> increased CO
▪ Valsalva stops venous return
o Muscular contractions pumps venous blood back to heart -> one way valves
o Decreased compliance increases peripheral venous pressure -> C = ∆V / ∆P
- Mean circulatory pressure = equilibrium pressure in absence of flow (7mmHg)
o Infusion or vasoconstriction (SANS) will increase it, hemorrhage or an increase in
blood flow will decrease it
- Coronary circulation = primarily aerobic (FFA B-oxidation) but uses anaerobic glycolysis
in ischemic conditions -> greatest blood flow during diastole
o Active hyperemia = increased blood flow due to metabolic demands (primary
controller of blood flow)
▪ NO (cGMP) & PGI2 (cAMP) induce vasodilation during exercise
▪ Adenosine increases cAMP -> vasodilation in ischemia
▪ Endothelial dysfunction (atherosclerosis) increases endothelin release
which decreases NO/PGI2 release
o Reactive hyperemia = increased blood flow due to vasoconstriction
▪ Myogenic response = increased pressure -> increased vessel diameter and
wall stress -> myogenic vasoconstriction to decrease vessel diameter and
wall stress
o Rate pressure product = indicates myocardial uptake of O2
EKG
- Signs = dilated ventricles & pulmonic vessels, Kerley lines (fluid between lung lobes),
heart failure cells (hemosiderin laden macrophages in alveoli)
- Diagnosis = ECG (blocks, arrythmias), echocardiogram (ejection fraction), exercise
testing, coronary arteriography
- NYHA classification = I (no limitations in activity), II (slight limitation), III (marked
limitation), IV (no physical activity)
- HFrEF = systolic dysfunction due to decreased contractility -> poor pumping -> decreased
SV and EF < 50%
o Symptoms = paroxysmal nocturnal dyspnea, orthopnea, hemoptysis, chest pain,
fatigue, nocturia, elevated HR/respirations, diaphoresis, left sided hypertrophy,
systolic murmurs (mitral regurgitation – S3 gallop), pulmonary edema, etc.
- HFpEF = diastolic dysfunction due to decreased ventricular compliance -> poor
ventricular relaxation and filling -> decreased EDV -> decreased SV but EF remains > 50%
o Usually due to left sided heart failure or hypertension
o Isolated right heart failure = in patients with lung parenchymal or vasculature
disease (cor pulmonale)
o Symptoms = systemic edema, right sided hypertrophy, portal hypertension,
hepatosplenomegaly, nutmeg liver, hepatic centrilobular necrosis, ascites
- Decompensation = increased fluid retention and cardiac remodelling -> arrythmias,
valve failure -> low CO + high venous pressure -> decreased tissue perfusion -> low renal
fluid excretion -> edema and congestion
o Cytokines mediate cardiomyocyte cell death in heart failure = TNFa, IFNy, Il-1, Il-6
release -> NFkB -> inflammation pathway -> apoptosis -> fibrosis
- Hypertensive heart disease = left ventricular diastolic dysfunction + left ventricular
hypertrophy + heart failure due to systemic hypertension
o Normotensive = no hypertension in any situation
o Sustained hypertension = hypertension in all situations
o Masked hypertension = no hypertension in clinic, hypertension at home
o White coat hypertension = hypertension in clinic, no hypertension at home
o Isolated systolic hypertension = increased systolic BP, normal diastolic BP -> in
elderly secondary to increased CO
EKG abnormalities
- Left ventricular hypertrophy = left axis deviation, ST depression and T inversion (I, aVL,
V5, V6)
- Right ventricular hypertrophy = right axis deviation, ST depression and T inversion (III,
V1-4)
- Wave abnormalities
o Tall P wave = right atrial hypertrophy (cor pulmonale, tricuspid stenosis)
o Bifid P wave = left atrial hypertrophy (mitral stenosis)
o Small QRS = old MI, myocarditis, pericardial effusion
o Tall T wave = hyperkalemia, MI, pericarditis (notched)
- Dysrhythmias
o Sinus bradycardia = <60bpm, prolonged PR interval
o Sinus tachycardia = >100bpm, short PR interval
o Sick sinus syndrome = SA node dysfunction due to drugs, scarring, CAD, etc. in
patients >50 years -> bradycardia, tachycardia, bradycardia-tachycardia
syndrome, sinus arrest
o Sinus arrythmia = variant R-R interval due to breathing -> increases during
inspiration, decreased during expiration
o Sinus arrest = cardiac standstill due to failure of SA node firing
o Premature atrial contraction = due to ectopic pacemaker -> irregular rhythm,
may have compensatory pause
o Atrial flutter = consistent re-entry pathway causing saw-tooth appearance, no PR
interval, ventricular rate can be regular or irregular
o Atrial fibrillation = patients >75 years with hypertension, atrial hypertrophy,
diabetes, CHF, left ventricular dysfunction, thyrotoxicosis, etc. -> multiple
re-entry pathways, no P waves, irregularly irregular ventricular rhythm -> chest
pain, exercise intolerance, risk of thrombus formation (stroke) -> control rate
(defibrillator or drugs) + give anticoagulants + ablative therapy + pacemaker
▪ Wolf-Parkinson-White syndrome = re-entry via bundle of Kent causing
atrial flutter or fibrillation -> short PR interval, delta wave (slurred QRS
upstroke), prolonged QRS
o Paroxysmal supraventricular tachycardia = due to re-entry pathway between
ventricles and atria -> regular tachycardic ventricular rhythm with narrow
(orthodromic) or wide (antidromic) QRS complexes -> defibrillation if unstable,
vagal maneuvers (carotid massage, Valsalva, cold water to face) if stable
o Premature ventricular contraction = ectopic impulse within ventricle, QRS >0.12s
o V-tach = >3 QRS complexes at a rate of >100bpm, due to ectopic pacemaker or
re-entry, no P waves, QRS >0.12s, can be monomorphic or polymorphic
▪ Torsades de Pointes = polymorphic V-tach due to re-entry in long QT
syndrome -> can degenerate into V-fib -> shorten QT interval with
magnesium
o V-fib = changing re-entry pathways, no rhythm or discernible waves, no
contraction, lethal -> defibrillator
o Asystole = no waves, fatal -> do not use defibrillator
- Conduction blocks
o AV block = PR >0.20s
▪ 1st degree = consistent, generally benign (high vagal tone) -> seen in
inferior MI, hypokalemia, hypomagnesia -> reduced exercise tolerance,
syncope, decreased first heart sound
▪ Mobitz I (2nd degree) = PR interval progressively increases until it is not
conducted to ventricles -> irregular ventricular rhythm -> seen in AV node
ischemia, hyperkalemia, etc. -> atropine or exercise removes condition
▪ Mobitz II (2nd degree) = consistent PR interval until it is not conducted to
ventricles at least twice consecutively -> irregular ventricular rhythm ->
requires pacemaker
▪ 3rd degree = no conduction to ventricles via atria, ventricles assume AV
pacemaker rhythm -> regular slow ventricular rhythm (<50bpm) ->
pacemaker required
o Bundle branch block = QRS >0.12s
▪ LBBB = left deviation of axis, progression of W to M QRS complex from
lead V4 to V6
▪ RBBB = normal axis or right deviation, progression of M to W QRS
complex from lead V1 to V5
- MI = ST depression (subendocardial) or elevation + tombstoning (transmural) within the
first few hours -> T wave inversion hours to days after -> permanent Q wave in stable
chronic phase -> axis deviates away from site of injury
Ischemic heart disease
- Causes = coronary atherosclerosis, emboli or vasospasms
- Angina
o Chronic stable = due to ischemia (atherosclerosis) -> occurs on exertion -> ST
depression (1mm in exercise ECG) -> resolution on rest or medication
▪ Pain threshold decreased after meals,
o Unstable = due to thrombus -> can occurs during sleep/rest/exertion, gets worse
over time
o Prinzmetal = coronary vasospasm -> occurs at rest -> ST elevation
- MI = Lack of blood flow -> ischemia -> tissue recovery or death (depletion of ATP) ->
dead tissue replaced by fibrous scar
o Acute response = ATP depletion (first 10 seconds) -> loss of contractility (<2min)
-> reversible changes (1-10min) -> irreversible damage (>20min)
o Causes of death = arrythmia (immediate) -> cardiogenic shock (1-3 days) ->
rupture (3-7 days) -> cardiac failure (>7 days)
o Morphologic changes = no change (<6hrs) -> wavy fibre change (<2 days) ->
coagulative necrosis + neutrophils (2-4 days) -> macrophages (5-7 days) ->
granulation tissue (7-10 days) -> organization of infarct (1-6 weeks) -> collagen
deposition (1-3 months)
o Types
▪ Transmural = due to thrombus/plaque change -> ST elevation
● Can be cause by cocaine
▪ Subendocardial = most susceptible to infarct -> due to atherosclerosis,
global ischemia, quick reperfusion -> ST depression
o Coronary steal phenomenon = dilation of vessels to non-ischemic myocardium
thereby decreasing blood flow to ischemic myocardium
▪ Dilation can be due to exercise or drugs
o Diagnostics
▪ CKMB = falls by 3rd day -> used to diagnose secondary MI
▪ Troponin = falls by 7th day -> used to determine myocardial necrosis
o Complications = arrythmias, reinfarction, Dressler’s syndrome (autoimmune
pericarditis), aneurysm and rupture, cardiac tamponade, heart failure
- Myocardial stunning = reversible contractile impairment due to ischemia
o Hibernation = cumulative stunning due to recurrent bouts of ischemia
- Contraction band necrosis = due to reperfusion in persistent myocardial ischemia (dead
myocytes) -> neutrophil influx, free radicals, Ca overload, membrane disruption
Arteriosclerosis
- Atherosclerosis = buildup of atherosclerotic plaque -> narrowing of arteries
o Injury = hyperlipidemia, HT (shear stress), tobacco, inflammation, infections ->
effects = lipid accumulation/free radicals, cytokines, necrosis, apoptosis,
thrombosis -> repair = fibrosis
o Risk factors = age, gender, genetics, diabetes, hyperlipidemia, HT, smoking
(primary preventable risk factor), homocysteine, metabolic syndrome
o Hyperlipidemia -> increased circulating LDL -> acylated or oxidized (LOX1) ->
taken up by macrophages (scavenger receptor) -> foam cells -> fatty streak ->
increased adhesion + inflammation -> extracellular lipid accumulation -> fibrous
plaque (lipid core + fibrous cap) -> complicated lesion (intima + media) ->
unstable plaque -> rupture -> thrombus
▪ Oxidized LDL is chemotactic (inflammation), toxic, increases adhesion
▪ Risk of rupture = large lipid core, thin cap, decreased SMCs, increased
macrophages, inflammation, metalloprotease
▪ Statins -> downregulate LOX1, inhibit HMG-CoA reductase, reduce CRP
o Clinical presentation = angina, TIA, intermittent claudication, renovascular HT,
mesenteric ischemia
- Monckeberg medial calcific sclerosis = dystrophic calcification of tunica media in the
lower limb arteries (pipe stem rigidity) or breast (railroad track) of elderly patients -> no
luminal narrowing, usually asymptomatic
- Myocardial bridges = burrowing of coronary vessels into myocardium -> usually
asymptomatic -> prone to coronary steal if given vasodilators
o Proximal segment prone to atherosclerotic plaques
o Diagnosis = half-moon sign (ultrasound), fingertip phenomenon (doppler
measurements), milking effect
Circulatory shock = imbalance between blood supply and demand -> nonprogressive (normal
compensatory mechanisms) -> progressive (therapy required) -> irreversible (end organ
damage) -> death
- Cardiogenic = due to arrythmia, HF, MI, cardiomyopathy, etc.
- Obstructive = cardiac tamponade, tension pneumothorax
- Neurogenic = loss of sympathetic outflow due to spinal injury
- Septic = due to infection
- Anaphylactic = IgE mediated allergic reaction
- Hypovolaemic = hemorrhage, burns, dehydration, etc.
Pharmacology
Antihypertensives
- a1 blockers = Prazosin, tamsulosin -> cause vasodilation and decrease TPR
o Therapeutic uses = hypertension with BPH + good lipid profile
▪ Combined with B-blockers or diuretic
o ADR = first dose syncope, reflex tachycardia, postural hypotension
- B-blockers = decrease CO (negative ionotropy/chronotropy) + renin release
o Therapeutic uses = performance anxiety, glaucoma, hypertension, MI,
pheochromocytoma (with a1 blockers first), arrythmias, migraines
o ADR = bronchospasm, sedation, masks hypoglycemia (insulin drugs), poor lipid
profile, sexual dysfunction, precipitate vasospasm (Prinzmetal angina, PVD),
additive depression (digitalis, verapamil), decreased effectiveness with NSAIDs,
rebound angina
o Non-selective B blockers = propranolol, timolol -> also used in glaucoma
o B1 blockers = atenolol, esmolol, metoprolol -> safe for asthmatics/COPD patients
▪ Esmolol is short acting -> acute SVT
o B-blockers with ISA = pindolol, acebutolol -> useful in HTN with DM, PVD,
asthma/COPD, abnormal lipid profile
o Mixed B blocker = labetalol (pheochromocytoma) and carvedilol (congestive
heart failure, pregnancy)
- a2 agonists = clonidine, methyldopa -> reduce sympathetic flow from vasomotor center
o Therapeutic uses = hypertension in pregnant/renal failure patients (methyldopa),
opiate withdrawal
o ADR = sedation, increased prolactin/positive Coombs test (methyldopa), edema,
rebound hypertension
- Ganglionic blockers = trimethaphan
- Hormone synthesis inhibitors = reserpine, guanethidine (blocked by cocaine), bretyllium
- Calcium channel blockers -> block L-type Ca channels in arteries
o Therapeutic uses = HTN patients with asthma/DM/PVD/angina, arrythmia,
cerebral vasospasm (nicardipine)
o ADR = constipation (verapamil), reflex tachycardia/ginigival hyperplasia (dipines),
peripheral edema
o Verapamil, diltiazem = cardiac vasodilators
▪ Contraindicated in CHF/AV block
o Dihydropyridine = nimodipine -> vascular vasodilators
▪ Increased risk of MI (reflex tachycardia) with short acting nifedipine
- Direct acting vasodilators
o Hydralazine = release NO -> arteriolar dilation -> pregnancy induced HTN -> can
cause edema, reflex tachycardia, Lupus like syndrome
o Nitroprusside = release NO -> vasodilation -> hypertensive emergencies ->
tolerance resistant -> can cause CN poisoning
▪ CN poisoning treatment = nitrite + sodium thiosulfate/B12
o Minoxidil/diazoxide = open K channels -> arteriolar dilation -> HTN, baldness
- D1 agonist = fenoldopam -> arteriolar dilator -> increases renal perfusion -> HTN with
renal insufficiency -> can cause glaucoma
- ACE inhibitors = captopril -> blocks ATII formation -> vasodilation, decrease aldosterone
o Therapeutic uses = HTN, protects against diabetic nephropathy, CHF (decreases
preload AND afterload + blocks heart remodelling), post MI
o ADR = dry cough (bradykinin), hyperkalemia, angioedema, teratogenic, not used
in bilateral renal artery stenosis
- ARBs = losartan -> blocks ATI receptor -> same effects as ACE inhibitors WITHOUT dry
cough
- Renin inhibitor = aliskiren -> can cause diarrhea and acute renal failure
- CA inhibitors = acetazolamide -> block Na/H exchanger in PCT
o Therapeutic uses = glaucoma, acute mountain sickness, metabolic alkalosis,
alkalinize urine, epilepsy
o ADR = acidosis, hypokalemia, renal stones
- Loop diuretics = furosemide, bumetanide, ethacrynic acid -> block Na/K/2Cl transport in
ALH + increased PG synthesis (vasodilation)
o Therapeutic uses = acute pulmonary edema (CHF), HTN, edema
o ADR = alkalosis, NSAIDs block vasodilation, hypokalemia, hypomagnesia,
hypovolemia, HSR (furosemide = sulfa drug), hyperuricemia, ototoxicity (don’t
use with aminoglycosides)
- Thiazide diuretics = chlorothiazide -> blocks Na/Cl symporter in DCT + enhances Ca
resorption + opens K channels (vasodilation)
o Therapeutic uses = HTN, edema, nephrogenic diabetes insipidus, kidney stones
o ADR = alkalosis, hypokalemia, hyperuricemia, hyperglycemia, hypercalcemia,
hyperlipidemia
- K sparing diuretics = spironolactone, eplerenone-> blocks aldosterone induced proteins
in collecting duct
o Amiloride/triamterene does not depend on aldosterone
o Therapeutic uses = hyperaldosteronism, prevents cardiac remodelling
(spironolactone), nephrogenic diabetes insipidus (amiloride)
o ADR = acidosis, hyperkalemia, gynecomastia/dysmenorrhea
- Osmotic diuretics = mannitol -> water excretion along entire tubule -> used for
glaucoma, increase ICP
IHD/angina drugs
- Nitrates = release NO -> increased cGMP -> dephosphorylation of MLC -> SMC relaxation
-> decrease preload (venodilation) + increase collateral circulation + relieve vasospasm
o Therapeutic uses = acute angina, stable angina (+ B blockers), Prinzmetal angina
(+ Ca channel blockers), CN poisoning, esophageal spasm, biliary colic
o ADR = tachyphylaxis (overcome via nitrate free period), postural hypotension,
reflex tachycardia, methemoglobinemia, severe hypotension if given with Viagra
- Dipyridamole = coronary vasodilator -> worsens angina (coronary steal)
- Ca channel blockers = verapamil, diltiazem, dipines = arteriolar/coronary vasodilation ->
decrease afterload -> used for all angina, especially Prinzmetal angina
- B blockers = decrease force of contraction and HR -> decreased O2 demand + blocks
reflex tachycardia -> increased exercise tolerance (stable angina)
o Pindolol/acebutolol (ISA) contraindicated
- Ranolazine = reduces late Na current -> reduced Ca concentration -> less diastolic
tension
- Trimetazidine = pFOX inhibitor -> inhibits b-oxidation pathway in cardiomyocytes
- Ivabradine = inhibits funny Na channel -> bradycardic drug
- Aspirin = low dose inhibits TXA2 -> decreased platelet aggregation
- Morphine = decreases preload and HR
CHF drugs
- Low salt diet, avoid NSAIDs/B-blockers/Ca channel blockers (verapamil, diltiazem)
- Ionotropic agents = increase contractility
o Digoxin/digitoxin = inhibit Na/K pump -> blocks Na/Ca exchanger -> more
intracellular Ca -> increased contractility without increased O2 demand +
increased vagal activity + decreased sympathetic activity
▪ ADR = narrow TI (excreted in urine), GI distress, vision disturbance,
▪ Toxicity = causes arrythmias -> exacerbated by quinidine, hypokalemia,
verapamil -> treat with atropine or digibind (anti-digoxin Abs)
o Dobutamine = B1 agonist -> acute heart failure
▪ ADR = tachyphylaxis
o Dopamine = D1 agonist -> cardiogenic shock in MI
o Amrinone/milrinone = PDE3 inhibitor -> increased cAMP -> increase contractility
+ decrease afterload (vasodilation)
- Diuretics = decrease preload and afterload
o Spironolactone -> prevents cardiac remodelling
▪ ADR = endocrine abnormalities -> use eplerenone
- Vasodilators = decrease preload and afterload
o Captopril = ACE inhibitor -> vasodilation + reduced Na retention + prevents
cardiac remodelling
▪ ADR = dry cough, hyperkalemia, teratogenic
o Losartan = ARB -> patients intolerant to ACE inhibitors (no dry cough)
o Sacubitril = inhibits neprilysin -> increased natriuretic peptide release
o Nesiritide = recombinant BNP -> vasodilation -> acute decompensated HF
o Hydralazine/nitrates = NO -> decreases afterload/preload -> decompensated
refractory HF
- B blockers = decrease cardiac remodelling -> for chronic HF management
Antiarrhythmics
- Class Ia = block open/activated Na channels -> increase AP duration + ERP
o Quinidine = used for a-fib
▪ ADR = proarrhythmic due to muscarinic/a1 block, cinchonism (tinnitus, GI
distress, etc.), prolonged QRT/QT interval, hypokalemia
o Procainamide = also blocks K channels -> less autonomic effects
▪ ADR = Lupus like syndrome, hematotoxicity
- Class Ib = block inactivated Na channels -> decrease AP duration + ERP
o Lidocaine = DoC for post-MI ventricular arrythmia
▪ ADR = seizures
- Class Ic = non-selective Na channel block
o Flecainide = very proarrhythmic -> last resort
- Class II = B blockers -> decrease SA/AV node activity -> prolong ERP -> used for V-fib
o Therapeutic uses = pheochromocytoma/halothane arrythmia, SVT (esmolol),
prophylaxis in post-MI
- Class III = K channel blockers -> increased AP duration + ERP
o Amiodarone = used for all arrythmias
▪ ADR = pulmonary fibrosis, blue skin
- Class IV = Ca channel blockers -> decrease nodal activity
o Verapamil/diltiazem = used for SVT
▪ ADR = AV block, constipation
- Unclassified
o Adenosine = decrease nodal activity -> DoC for PSVT/AV nodal arrythmias
▪ ADR = bronchospasm, higher dose in tea drinkers
o Magnesium = used in torsades
Drugs for dyslipidemia
- Statins = HMG-CoA reductase inhibitors -> decrease LDL
o ADR = rhabdomyolysis when combined with niacin, fibrates, verapamil or
amiodarone, hepatotoxicity
- Niacin = decrease HSL in adipose tissue -> increase HDL
o ADR = flushing/pruritis (take aspirin), hyperuricemia, acanthosis nigricans
- Fibrates = activate PPARa + LPL -> decreases TAG
o ADR = gallstones, myopathy
- Cholestyramine/colestipol/colesevelam = bile acid sequestrants -> used in isolated
increases of LDL
- Ezetimibe = inhibits intestinal cholesterol absorption -> decreased LDL
- EPA/DHA = fish oils -> decreased TAG
- Alirocumab/evolocumab = PSCK9 inhibitors -> improves LDL clearance
Cardio
Pathophysiology
Inflammatory heart disease
- Endocarditis
o Infectious = usually bacterial and left sided -> fever, Janeway lesions, splinter
hemorrhage, Roth’s spots, Osler nodes (red tender blanchable nodules on
fingers/toes), large irregular vegetations on valve cusps that extend into chordae
▪ Prosthetic valve endocarditis with metallo-B-lactamase producing
pseudomonas
▪ Predisposing factors = endothelial injury, turbulent flow, bacteremia,
IVDU, dental procedures, cardiac surgery, etc.
● Right sided seen in IVDU (S. aureus, pseudomonas)
o Give Nafcillin -> vancomycin in MRSA
▪ Prophylaxis (vancomycin + rifampin + gentamycin) given in patients with
prosthetic heart valves, previous infective endocarditis, congenital heart
diseases, transplant patients
o Non-infective = seen in patients with malignancy (mucinous adenocarcinoma),
hypercoagulability, scarred valves
▪ Nonbacterial thrombotic/marantic endocarditis = small vegetations
attached to lines of closure -> seen in hypercoagulability states
(paraneoplastic syndromes)
▪ Liebman-Sacks endocarditis = seen in SLE -> eosinophilic vegetations on
both sides of AV valves, fibrosis and deformity
- Myocarditis = causes dilated cardiomyopathy, patchy necrosis
o Infectious
▪ Chagas (T. cruzi) -> dilated myocardiopathy
Respi
Anatomy
- Thoracic wall = made up of 12 ribs, sternum and vertebrae
o Movement = anteroposterior (rib 1-6 pump handle), transverse (rib 7-10 bucket
handle), vertical (diaphragm)
- Pleura = parietal (pain sensitive) and visceral (pain insensitive)
o Recesses = costomediastinal and costodiaphragmatic
o
- Alveoli = type I pneumocytes (endoderm) for gas exchange, type II pneumocytes
(splanchnic mesoderm) secrete surfactant
Physiology
Pulmonary system
- Pulmonary functions = ventilation, gas transfer, acid-base balance, enzymes (NO, ACE),
phonation, defense mechanisms (mucocilliary apparatus)
- Gas flow = convection/mass flow in airways/blood, diffusion across membranes in
alveoli/target tissues
- Respiratory apparatus = trachea -> bronchi -> bronchioles -> alveolar ducts -> alveoli
o No cartilage bronchioles onward -> more prone to obstruction
o Respiratory membrane = lipid soluble gases (O2/CO2) readily diffuse through
alveolar/capillary membranes
- Mechanics of breathing
o Inspiration = descent of diaphragm + elevation of ribs -> chest cavity expansion
▪ Forced inspiration -> external intercostals + accessory muscles
o Expiration = passive relaxation of diaphragm + elastic recoil
▪ Forced expiration -> internal intercostals + abdominal muscles
- Lung volumes
o Vt = normal breathing (500mL)
o IRV = maximal inhalation above Vt (3000mL)
o ERV = maximal exhalation below Vt (1100mL)
o RV = volume remaining in lung after maximal exhalation (1200mL)
o IC = Vt + IRV
o FRC = IRV + RV
o VC = Vt + IRV + ERV
o TLC = Vt + IRV + ERV + RV
- Pulmonary circulation = right atrium -> pulmonary arteries (deoxygenated) -> respiratory
exchange -> pulmonary veins (oxygenated) -> left atrium
- Bronchial circulation = bronchial arteries from aorta carry oxygenated blood to lung
parenchyma -> drain into pulmonary veins (venous admixture)
- Pulmonary hemodynamics = equal flow to system circulation but lower resistance and
arterial pressure due to increased compliance
o Exercise = increased CO -> recruitment of nonperfused capillaries + distension
o Hemorrhage = decrease in CO -> decruitment of capillaries + vasoconstriction
o Regional blood flow = greater blood flow/perfusion at base of lungs due to
gravity
o Net filtration pressure = greater in pulmonary system -> compensated by
increased lymphatic drainage
▪ Pulmonary edema -> increased capillary pressure (left sided heart
failure), capillary permeability, interstitial colloid oncotic pressure,
alveolar surface tension (decreased surfactant) OR decreased plasma
colloid oncotic pressure
▪ Pleural effusion = accumulation of fluid in pleural cavity -> blockage of
lymphatic drainage, right heart failure, decreased plasma colloid oncotic
pressure, increased capillary permeability
- Pulmonary vascular resistance = lowest at FRC
o On inspiration -> alveolar vessel are compressed (increased resistance) and
extra-alveolar vessels are relaxed (decreased pressure) -> opposite on inspiration
o PVR increased -> compression of vessels, increased blood viscosity
o PVR decreased -> increased pulmonary pressure/blood volume, increased left
atrial pressure, gravity (hydrostatic)
o Hypoxic pulmonary vasoconstriction = hypoxia/hypercapnia/low pH induce
vasocontraction in pulmonary vessels increasing PVR (opposite for systemic
vascular resistance)
▪ Regional hypoxia -> diversion of blood to well ventilated areas
▪ Global hypoxia -> generalized increase in PVR -> can lead to pulmonary
hypertension
Mechanics of ventilation
- Respiratory pressures = lungs tend to collapse, chest well tends to expand -> balance
between collapsing and expanding pressures at FRC
o Intrapleural pressure = negative at rest due to lymphatic suction and lung/chest
elastic forces -> decreases during inspiration
o Alveolar pressure = 0 at rest -> decreases on inspiration
o Transpulmonary pressure = alveolar pressure – intrapleural pressure
▪ Transpulmonary pressure = lung elastic recoil = increases with inspiration
- Lung compliance = ∆V / ∆P -> distensibility
o Lung expansion -> compliance decreases and elasticity increases -> both lung and
chest wall tend to recoil inward at high lung volume
o Hysteresis = separation of curves in the lung pressure-volume loop
- Lung elasticity = tendency for lung to recoil -> determined primarily by alveolar surface
tension then elastic properties of lung parenchyma
o Alveolar surface tension = collapse prevented by surfactant and alveolar
interdependence
▪ Preterm infants lack surfactant (lecithin:sphingomyelin < 2:1) -> smaller
alveoli tend to drain into larger one and collapse -> atelectasis
- Airflow = Q = ∆P / R
o Laminar flow = slow velocity in small airways
o Turbulent flow = fast velocity in large airways
- Airway resistance = resistance to airflow mainly due to friction
o Greatest total resistance in medium sized bronchi, smaller airways more prone
to occlusion
o Increased lung volume -> increased tension in alveolar walls -> pulling open
airways (traction effect) -> decreased airway resistance
o Sympathetic stimulation decreases airways resistance -> bronchodilation (B2),
decreased mucus secretion while
- Equal pressure point = level in airway where intrapleural pressure equals airway
pressure -> above EPP is compressing force by higher intrapleural pressure
o EPP lowers towards alveoli during forced expiration -> increased airway
resistance and airway limitation
o EPP is on larger airways at high lung volumes -> no airway limitation -> airflow
rate is effort dependent
▪ At lower lung volumes -> airflow rate is effort independent
- Work of breathing = decreased lung compliance + increased airflow resistance ->
increased work of respiration
- Alveolar ventilation = (Vt – Vd) x breaths/min
o Physiological dead space = air that does not participate in gas exchange =
anatomical dead space + alveolar dead space
o End of expiration -> anatomic dead space filled with alveolar air
▪ Air sample near end of inspiration is alveolar air
o End of inspiration -> anatomic dead space filled with atmospheric air
o Base of lung has better alveolar ventilation as the apex is less compliant
- Alveolar gas equation – PAO2 = PiO2 – (PaCO2/R)
- Closing capacity = lung volume at which airways begin to collapse -> less than FRC
- PFT = use spirometry and diffusion capacity of CO to determine pulmonary function
o Advanced PFTs = arterial blood gas, exercise oximetry, 6 minute walk test, peak
flow, maximal inspiratory/expiratory pressures
o Spirometry = measurement of lung volumes
▪ FEV1 = forced expired volume in 1 second -> indicative of expiratory
resistance
● FEV25-75% = scooping seen in obstructive lung diseases
▪ RV/FRC/TLC cannot be measured via spirometry
▪ Decreased DLCO
o Aging = increased lung compliance and decreased elastic recoil -> slight increase
in RV/FRC
o Asthma = reversible increase in airway resistance due to bronchospasm and
increased mucus secretion
▪ FEV1 improved with bronchodilators
▪ Increased DLCO
- Restrictive lung disease = intrapulmonary (fibrosis, sarcoidosis, atelectasis, ) or
extrapulmonary (obesity, scoliosis, kyphosis, neuromuscular disorders, pneumothorax)
-> decreased compliance
o FEV1 and FVC are proportionately decreased, FEV1/FVC is normal or above
normal, all lung volumes/capacities are decreased -> compliance curve shifts to
the right
o Pneumothorax = intrapleural pressure equalizes with atmospheric pressure ->
chest wall springs out and lungs collapse -> decreased lung compliance
▪ Tension pneumothorax = mediastinal shift, decreased venous return/CO
Respi
Physiology
- Cell types = type I pneumocytes (gas exchange), type II pneumocytes (surfactant,
replace type I pneumocytes), alveolar macrophages
o Pores of Kohn equalize pressure between alveoli
o Canals of Lambert form bronchoalveolar connections
- Gas flows according to pressure gradients (high to low)
o Tissue gas pressure determined by rate of blood flow and tissue consumption
o Increased O2 demand -> PaO2 maintained by better V/Q matching + increased
O2 extraction -> PvO2 is decreased
o Increased CO2 production -> PaCO2 maintained by increased blood flow +
alveolar excretion
- O2 delivery = determined by ventilation, perfusion and V/Q matching and O2 carrying
capacity (dissolved O2 + Hb concentration + Hb affinity)
o Hb = 4 binding sites for O2 (ferrous form) -> increased affinity as more O2 binds
▪ Ferric Hb = methemoglobin -> cannot bind O2
▪ Hb binding capacity = 1.34mL O2 / g Hb
- O2 dissociation curve
o Left shift = increased O2 affinity -> fetal Hb, Hbs (sickle cell), CO poisoning
▪ CO poisoning = CO binds with much higher affinity to Hb than O2 -> [Hb]
and PaO2 are normal + blood is cherry red (no cyanosis) -> no feedback
mechanism -> use CO oximetry
o Right shift = decreased O2 affinity -> increased PCO2/H+/2,3-BPG/temp
(exercise) -> increased O2 delivery to tissues
▪ Increased 2,3-BPG in prolonged hypoxia -> further shift to right
- CO2 transport = mainly carried as bicarbonate from tissues to lungs
o Chloride enters RBC in exchange for bicarbonate at tissues -> increase venous pH
o Haldane effect = binding of O2 displaces CO2 -> CO2 excretion from lungs
- Myoglobin = 1 higher affinity O2 binding site -> greater concentration in slow twitch
muscles -> used at low PO2 (decreased perfusion)
- A-a gradient = PAO2 – PaO2 -> usually 5-15mmHg
o PAO2 = [(Pb – H2O) x FiO2] – [PaCO2 / 0.8]
o PaO2 decreases with aging -> increased gradient
- Fick’s law of diffusion = diffusion directly proportional to pressure gradient + surface
area + solubility, inversely proportional to membrane thickness
- Diffusion capacity = amount of gas that will diffuse per minute per mmHg
o DLO2 determined via DLCO -> O2 1.23x more diffusible than CO
o DLO2 increases during exercise due to increased blood flow/ventilation + V/Q
matching
o Diffusion limitation = equilibration NOT achieved between alveolar and capillary
gas pressure -> CO, O2 (thick membrane -> fibrosis)
o Perfusion limited = equilibration achieved (PAGas = PaGas) between alveolar
and capillary gas pressure -> CO2, O2 (normal)
▪ O2 still equilibrates in heavy exercise due to large O2 diffusion reserve
- V/Q = usually is 0.8 giving a PaO2 of 100mmHg & PaCO2 of 40mmHg
o Apex -> low V (high pleural pressure, larger alveoli, less compliant) and low Q ->
higher V/Q ratio -> blood from apex is more oxygenated
o Base -> high V (small alveoli, more compliant, gravity) and high Q (distended
veins) -> lower V/Q ratio -> blood from base contributes to physiologic shunt
o Despite O2 equilibration, PaO2 is always less than PAO2 due to physiologic
shunts -> bronchial venous blood + thebesian veins + low V/Q at base
- Respiratory center = primarily in the medulla
o Dorsal respiratory group = quiet respiration -> repetitive inspiratory ramp
signals that increase in intensity -> diaphragmatic contraction -> abrupt cessation
of signal (inspiratory off switch) -> diaphragmatic relaxation
▪ Respiratory rate controlled by altering slope of ramp signal (apneustic
center in lower pons) and inspiratory off switch (pneumotaxic center in
dorsolateral pons)
o Ventral respiratory group = inspiratory and expiratory signals -> inactive during
quiet respiration
- Respiratory receptors
o Pulmonary stretch receptors = slow adapting, sense airway stretch/lung volume
▪ Hering-Breuer reflex = excitation of pulmonary off switch + prolongation
of expiration -> prevent lung over inflation
o Irritant receptors = stimulated by irritants -> causes coughing, gasping,
prolonged inspiration
o J receptors = stimulated by lung injury
o Chest wall proprioceptors = stimulated when breathing movements are opposed
o Central chemoreceptors = sensitive to acute increase H+ (due to increased
PCO2) -> increases respiratory drive
▪ Chronic increase in CO2 is compensated by the kidneys
o Peripheral chemoreceptors = carotid/aortic bodies -> sensitive to low PaO2
(strong stimulus) + high PCO2 (rapid stimulus) + reduced pH
- Respiration during exercise = PaO2/PaCO2 are normal during exercise due to
compensatory increase in ventilation and perfusion + better V/Q matching
- Types of respiration
o Voluntary hyperventilation = decreased PaCO2, increased pH
▪ Hyperventilation syndrome -> vasoconstriction -> cardiac/cerebral
symptoms + alkalosis -> hypocalcaemia (Trousseau/Chvostek sign) +
hypokalemia (weakness)
o Voluntary hypoventilation = decreased PaO2, increased PaCO2 -> break point
where breathing can no longer be inhibited
o Cheyne-Stokes respiration = cyclic hyperpnea and apnea
o Kussmaul’s respiration = rapid deep breathing to compensate for metabolic
acidosis
- Altitude acclimatization = decreased PiO2 -> decreased PAO2 -> decreased PaO2 ->
peripheral chemoreceptors triggered -> hyperventilation -> decreased PaCO2 ->
respiratory alkalosis -> decreased ventilation -> increased excretion of bicarbonate and
H+ retention (renal compensation) -> decreased pH -> increased ventilation
o Acute mountain sickness = headache, nausea, vomiting, fatigue within first week
o Chronic mountain sickness = increased RBCs + pulmonary hypertension ->
enlarged right heart -> heart failure
o High altitude cerebral edema = hypoxia induce vasodilation of cerebral vessels
causing fluid leak into brain tissue
o High altitude pulmonary edema = unequal hypoxic vasoconstriction of
pulmonary vessels causing fluid leak into lung tissue
Pathophysiology
- Anemia = decrease in Hb concentration
o PaO2 and SaO2 are normal -> in severe anemia 2,3-BPG increases to maintain O2
delivery to tissues
o Cyanosis ≥ 5g/dL deoxygenated Hb -> in anemia cyanosis appears at much lower
SaO2/PaO2
- Hypoxemia = decreased blood O2 content
o Normal A-a = hypoventilation, low Pi (high altitude), anemia, ischemia,
methemoglobinemia
▪ Low PCO2 at high altitudes (compensatory hyperventilation) vs high PCO2
in hypoventilation
o Increased A-a = V/Q mismatch, congenital R-L shunt, impaired diffusion (fibrosis,
edema, pneumonia, emphysema), aging
▪ V/Q = 0 -> ventilation defect with normal perfusion (severe obstructive
lung disease, atelectasis, blocked airway) -> alveolar gas = venous gas =
low PO2, high PCO2 -> wasted blood/shunt
▪ V/Q = ∞ -> perfusion defect with normal ventilation (pulmonary
embolism) or excess ventilation (hyperventilation) -> capillary gas =
alveolar gas = atmospheric gas = high PO2, low PCO2 -> wasted air
- Hypoxia = failure of O2 delivery or use at the tissue level
o Hypoxic hypoxia = hypoxemia -> decrease PaO2
o Anemic hypoxia = decreased [Hb] -> decreased O2 carrying capacity -> decreased
deliver of O2 -> PaO2 is normal
o Ischemic hypoxia = decreased blood flow to tissue
o Histotoxic hypoxia = tissue cannot make use of O2
- Nitrogen
o Inert gas narcosis = nitrogen dissolves into fatty tissue (brain) at increasing
depths -> altered ionic conductance reducing neuronal excitability
o Decompression sickness = quick ascent from the sea precipitates nitrogen
bubbles in the blood -> ischemia and death
Congenital disorders
- Peribronchiolar metaplasia = bronchial injury -> bronchiolar metaplasia in alveoli
- Pulmonary agenesis = complete absence of one or both lungs
- Pulmonary aplasia = absence of lung parenchyma, blind ended bronchus present
- Pulmonary hypoplasia = incomplete small lungs -> seen in congenital diaphragmatic
hernia or oligohydramnios
- Foregut cysts = abnormal detachment of primitive foregut -> usually in bronchus
(mediastinal) -> can also be in esophagus or upper GI
- Pulmonary sequestration = part of lung supplied by extrapulmonary blood flow
o Extralobular = infantile mass lesion usually left sided, covered by separate pleura
o Intralobular = in older children with recurrent infection/bronchiestasis
- Bronchial atresia = distal lung tissue hyperinflates and fills with mucus
- Lobar hyperinflation = lack of bronchial cartilage -> progressive over inflation in male
neonates -> obstruction/air trapping
- Congenital pulmonary airway malformation = bronchial development failure ->
harmatomatous proliferation of lung tissue -> multi cystic masses, absence of cartilage
and bronchial glands
- Primary ciliary dyskinesia = abnormal ciliary movement due absence of inner/outer
dynein arms (DNAH5 mutation) -> recurrent pulmonary infections, sinusitis, otitis media,
male infertility -> associated with situs inversus totalis (Kartagener syndrome)
Lung disorders
- Atelectasis = incomplete expansion (loss of surfactant, ARDS) or collapse of previously
expanded lung (acquired atelectasis) -> hypoxemia and infections
o Acquired atelectasis = complete obstruction (mucus, foreign body -> mediastinal
shift towards collapse), compression (tumor, pneumothorax -> mediastinal shift
away from collapse) contraction (fibrosis)
▪ Obstruction due to tumors/enlarge lymph nodes more common in right
middle lobe
▪ Catamenial pneumothorax = right sided in women 30-40 years 2-3 days
after menstruation
- Pulmonary edema = due to imbalance between hydrostatic and oncotic pressures
o Increased capillary hydrostatic pressure (impaired venous return) + interstitial
oncotic pressure + vascular permeability + sodium retention OR decreased
capillary oncotic pressure (hypoproteinemia) + interstitial hydrostatic pressure +
lymphatic drainage -> accumulation of fluid in interstitial space
▪ CHF -> increased venous pressure + sodium retention -> heart failure cells
(hemosiderin laden macrophages)
- Drug induced lung injury = bleomycin & amiodarone cause fibrosis, methotrexate &
nitrofurantoin cause HSR pneumonitis, aspirin & B blockers cause bronchospasms
- Radiation induced lung injury = can acutely cause lymphocytic alveolitis/HSR
pneumonitis, fever, pleural effusion -> chronically cause fibrosis, foam cells, atypia
- Sarcoidosis = systemic granulomatous disease in black women <40 years ->
noncaseating granulomas compressing alveoli, giant cells with Schumann/asteroid
bodies -> sudden shortness of breath, cough, chest pain, night sweats, fever, erythema
nodosum, lupus nernio, hypercalcemia, hyperIgG
Renal
Anatomy
- Kidney = nephron (functional unit), cortex (contains all glomeruli), medulla, papilla,
columns, calyces, pelvis, ureter (constricted at pelvic junction, pelvic brim, bladder)
o Uteric bud/mesenephric duct = forms collecting system (collecting duct + calyces
+ renal pelvis + ureter)
o Metanephric duct = forms excretory system (glomerulus + Bowman’s capsule +
PCT + loop of Henle + DCT)
▪ Basement membrane (negatively charged heparan sulfate) + slit
diaphragms (space between podocyte foot processes) + nephrin/podocin
molecules keep proteins out of Bowman’s capsule
▪ PCT has a brush border while DCT does not
- Urinary bladder = detrusor muscle (SMC of bladder -> forms internal urethral sphincter),
- Autonomics = pelvic parasympathetic splanchnic (S2-4) + sacral sympathetic splanchnic
(T12-L2) supply inferior hypogastric plexus -> innervate all smooth muscle + glands
Physiology
Renal circulation
- Hemodynamics = main method of altering RBF is by changing afferent/efferent arteriolar
resistance
o Greatest drop in renal pressure is in the afferent and efferent arterioles
o Increasing afferent or efferent resistance -> decreased RBF
o Increasing afferent resistance -> decreased glomerular pressure (GFR)
o Increasing efferent resistance -> increased GFR
- RBF/GFR control
o Sympathetic -> afferent vasoconstriction more than efferent -> decreased RBF
and GFR
o Angiotensin II -> afferent and efferent vasoconstriction + glomerular mesangium
constriction (decreased Kf) -> decreased RBF and GFR
o ANP -> afferent dilation + efferent vasoconstriction + + glomerular mesangium
relaxation (increased Kf) -> RBF remains the same but increased GFR
o Prostaglandin -> afferent dilation -> increased RBF and GFR
o NO -> afferent dilation -> increased RBF and GFR
- Tubuloglomerular feedback = when RBF/GFR are high -> increase Na delivery to macula
densa in DCT via NK2Cl transporter -> adenosine release -> afferent vasoconstriction ->
decreased RBF/GFR
o High protein/glucose diet -> increased Na coupled AA/glucose resorption ->
decreased Na in macula densa -> increased RBF/GFR
- GFR = NFP x Kf
o Net filtration pressure = glomerular hydrostatic pressure – [Bowman’s capsule
hydrostatic pressure + glomerular oncotic pressure)
o Filtration coefficient = depends on permeability and surface area
▪ GBM resists water movement, negatively charged glycocalyx prevent
protein movement
- Excretion = filtration + secretion – reabsorption
o Filtration fraction = GFR / RBF -> increasing filtration fraction increases capillary
colloid oncotic pressure
▪ Renal circulation passes 2 capillary beds progressively increasing the
capillary colloid oncotic pressure during filtration
o Filtered load = plasma concentration x GFR -> if no reabsorption/secretion then
urine excretion = filtered load
- Na transport ->
o Reabsorbed in PCT -> Na/H exchanger -> reduced H availability with CA inhibitors
o Reabsorbed in loop of Henle -> NaK2Cl transporter -> blocked by loop diuretics
o Reabsorbed in DCT -> NaCl symporter -> blocked by thiazide diuretics
o Reabsorbed in collecting tubule -> electrogenic Na channel -> blocked by K
sparing diuretic amiloride)
Urine formation
- Tubular transport = either passive (paracellular) or active (transcellular) but overall
coupled with Na transport
o Creatinine is mostly filtered (steady state production = excretion) -> creatinine
plasma concentration can be used to calculate GFR
o Inulin is fully filtered -> excretion = filtered load = GFR
o Glucose = transcellular reabsorption in PCT coupled to Na transport (SGLT)
o Amino acids = transcellular reabsorption in PCT coupled to Na transport
o Water = paracellular and transcellular (AQP) reabsorption
o Cl = transcellular reabsorption with sodium in TAL/DCT (NaCl/NaK2Cl) and
paracellular reabsorption
o PAH = transcellular -> fully secreted
o
- Transport ATPases
o Na/K -> Na reabsorption throughout nephron
o H/K -> H secretion in collecting tubules
o H-ATPase -> H secretion in PCT
o Ca-ATPase -> Ca reabsorption in DCT
- Ion channels
o K channels throughout nephron
o Aldosterone sensitive electrogenic Na channels in distal nephron for reabsorption
(blocked by amiloride/K sparing diuretics)
o PTH sensitive TRPV5 Ca channels in DCT (reabsorption)
- Exchangers
o Na/H exchanger -> acid-base regulation throughout the nephron
o Na/bicarbonate symporter -> acid-base regulation in PCT and TAL
o Cl/bicarbonate antiporter -> acid-base regulation in PCT and collecting duct
o NaK2Cl symporter -> reabsorption in the TAL -> primary effect on macula densa
in DCT (blocked by loop diuretics/furosemide)
o Na/PO3 symporter -> PO3 reabsorption in PCT
o Na/Cl symporter -> Cl reabsorption in the DCT (blocked by thiazide diuretics)
Pathology
Glomerular diseases
- Nephrotic syndromes – T-cell mediated glomerular injury causing proteinuria ->
hypoalbuminemia (causes hypocalcaemia and 2o hyperparathyroidism), generalized
edema, increased renin (2o hyperaldosteronism), decreased ANF, infections due to loss
of IgG, microcytic hypochromic anemia (loss of transferrin), thrombosis and
hypercoagulability due to decreased anticoagulants/antiplasmins, hyperlipidemia
o Minimal change disease = normal looking glomeruli but uniform/diffuse
podocyte foot process effacement in children -> protein/lipid laden PCT, selective
proteinuria (albumin) -> proteinuria stops with corticosteroids (biopsy children
that don’t respond)
o Focal segmental glomerulosclerosis = segmental sclerosis of glomeruli with
podocyte effacement -> non-selective proteinuria, deposition of
IgM/C3/anti-CD40 Abs, hyaline masses/lipid deposition, increase BUN ->
associated with HIV (collapsing FSFS w/ cystic tubular dilation) & heroin use,
more hematuria and HTN compared to MCD -> treated with RAAS inhibitors
▪ Congenital FSGS -> NPHS1/2 mutation (nephrin/podocin), a-actinin4
mutation, TRPC6A mutation
o Membranous nephropathy = subepithelial spike and dome deposits of
autoantibodies (HepB, SEL, etc.) in GBM in middle aged patients -> uniform
capillary thickening, nonselective proteinuria -> risk of DVT, renal vein thrombosis
and pulmonary embolism -> prophylactic anticoagulants
o Membranoproliferative glomerulonephritis = due to circulating immune
complexes (type I) or anti-C3 Abs (type II) -> proliferation of mesangial cells,
thickened GBM (tram track appearance)
MCD FSGS MN MPGN
- Nephritic syndromes – glomerular injury causing cell proliferation + inflammatory
infiltrate characterized primarily by hematuria with RBC casts -> oliguria & azotemia
(elevated BUN + creatinine) due to decreased GFR, HTN, variable proteinuria/edema
o Post strep glomerulonephritis = IgG/complement immune complex deposition
(subendothelial hump) + hypercellularity + neutrophil infiltrate 1-4 weeks post
GAS infection in children -> gross hematuria (smoky brown urine) -> can progress
to rapidly progressive GN
o IgA nephropathy (Berger’s diseases) = IgA deposition in mesangium due to
defective production/clearance after a GI/respi infection -> episodic gross
hematuria in children/young adults -> also seen in patients with Celiac disease
and liver disease (decreased clearance), responds to plasmapheresis
▪ Henoch-Schoenlein purpura = systemic IgA deposition (purpuric rash +
abdominal pain + nephropathy)
o Hereditary nephritis/Alport syndrome = X-linked dominant mutation of type IV
collagen a-chains, usually in males -> nephritis + ocular disorder + deafness ->
foamy interstitial cells, thick and thin basket weave GBM
▪ Female carriers present with persistent hematuria
o Thin membrane disease = diffuse thinning of GBM -> benign familial
asymptomatic hematuria
o Rapidly progressive glomerulonephritis = severe glomerular injury causing loss
of renal function for days to weeks microscopic -> hematuria with RBC casts,
severe oliguria, azotemia, crescents (proliferation of parietal cells in Bowman’s
capsule + fibrin deposition)
▪ Anti-GBM crescentic GN -> linear IgG/C3 deposits on GBM (type II HSR) ->
smooth GBM
● Seen in Goodpasture syndrome (also effects lungs)
▪ Immune complex GN with crescents -> seen in PSGN, SLE, Henoch
Schoenlein purpura, IgA nephropathy -> lumpy bumpy GBM
▪ Pauci-immuno crescentic GN = seen in Wegner’s and polyarteritis nodosa
(C/P-ANCA)
Alport Thin Membrane RPGN crescents
- Chronic GN = symmetric disease usually do to RPGN (also FSGN, MPGN, MN) ->
accumulation of hyaline masses transforming glomerulus into acellular eosinophilic mass
+ diffuse granularity on kidney surface -> proteinuria, HTN, azotemia, uremia (and
associated complications)
- Benign proteinuria = can be due to dehydration, stress, inflammation, intense activity
o Orthostatic proteinuria = increased proteinuria when upright but normal when
lying down -> annual BP and urinalysis to monitor patients
Tubulointerstitial diseases
- Tubulointerstitial nephritis = involves tubules/interstitium and spares glomerulus
o Acute pyelonephritis = suppurative ascending bacterial upper UTI usually in
sexually active women due to E. Coli or other enteric gram- rods (multifocal
infection due to hematogenous staph infection) -> fever, nausea, sudden
costovertebral tenderness, dysuria -> PMN infiltrate, yellow abscesses, renal
papillary necrosis, bacteriuria, pyuria (WBC casts)
▪ Risk factors = bladder/urinary tract obstruction (BPH in men, uterine
prolapse in women), diabetes, drug abuse, CAUTI, vesicoureteral reflux (in
children), pregnancy, etc.
o Chronic pyelonephritis = chronic interstitial inflammation -> asymmetric
pelvicalyceal scarring (flattened calyces underlying cortical scars) due to chronic
obstruction (unilateral) or chronic vesicoureteral reflux (bilateral) -> colloid casts
in tubules (thyroidisation)
o Xanthogranulomatous pyelonephritis = nephrolithiasis and obstruction due to
proteus infection in females -> accumulation of foamy macrophages + giant cells
+ large yellow nodular kidney
o Drug-induced interstitial nephritis = eosinophilia and rash (type I HSR) or
neutrophilia or granulomas (type IV HSR)
▪ NSAIDs cause concomitant MCD + interstitial nephritis
o BK infection = tubulointerstitial nephritis in kidney transplant patients -> large
homogenous inclusions in infected cells (decoy cells that look like cancer cells)
- Acute tubular injury = damaged tubular cells due to glomerular diseases, renal vascular
diseases or drug induced allergic interstitial nephritis -> redistribution of membrane
proteins -> decreased GFR + oliguria -> dirty brown casts
o Ischemic ATI = inadequate blood flow to kidneys due to shock/hypotension
(trauma, pancreatitis, septicemia) -> proteinaceous casts (Tamm-Horsfall protein,
hemoglobin) in distal nephron, tubular necrosis
o Nephrotoxic ATI = due to toxins, organic solvents, drugs (gentamicin), contrast
agents -> primarily effect PCT
Renal stones
- Renal calculi = struvite stones (alkaline pH, proteus), urate stones (acidic pH), cystine
stones (cystinuria) -> renal colic, hematuria, hydronephrosis
- Urate nephropathy = acute injury seen in chemotherapy, chronic injury causes gout ->
can progress to urate stones (nephrolithiasis)
- Myeloma nephropathy = Bence-Jones proteins & Tamm-Horsfall proteins form tubular
casts and induce granulomatous inflammation
- Hydronephrosis = urine flow obstruction -> dilation of renal pelvis/calyces -> cortical
thinning + renal atrophy
Renal vascular diseases
- Benign nephrosclerosis = due to chronic HTN (≥180/120) -> hyaline arteriosclerosis +
medial/intimal thickening -> bilateral leathery granular kidneys
- Malignant nephrosclerosis = due to malignant HTN (≥200/120) superimposed on
essential HTN/2oHTN/scleroderma/pheochromocytoma -> sudden increase in HTN
causes endothelial injury and increased permeability (protein leak) -> fibrinoid necrosis +
necrotizing vasculitis + thrombosis + onion skinned hyperplastic arteriosclerosis -> flea
bitten kidney
- Renal artery stenosis = due to atheromatous plaque (older men) or fibromuscular
dysplasia (younger women) -> chronically ischemic kidney causes constant renin release
-> HTN (surgically correctable) that eventually causes hyperplastic arteriosclerosis in
contralateral kidney
o Fibromuscular dysplasia can also cause strokes, MI, aneurysm and dissection ->
renal artery will have string of beads appearance
- Thrombotic microangiopathy = microangiopathic hemolytic anemia (schistocytes) +
thrombocytopenia (platelet-fibrin thrombi) + renal failure (cortical necrosis)
o HUS = EHEC (O157:7) or Shigella infection in children -> rapidly progressive renal
failure + hemorrhagic diarrhea
o TTP = ADAMTS13 deficiency -> altered mental status + fever + purpura
- Diffuse cortical necrosis = bilateral/symmetrical cortical necrosis due to conditions that
cause ischemia and DIC (HUS, TTP, abruptio placenta, etc.)
- Renal infarct = due to emboli from left heart -> flank pain, fever, leukocytosis,
proteinuria, hematuria -> wedge shaped pale
Congenital anomalies
- Fetal lobulation of kidney = normal renal function
- Horseshoe kidney = fusion of lower poles (ascent blocked by the IMA) -> seen in Turners
Cystic kidney diseases
- ADPKD = PKD gene (polycystin) mutation on chromosome 16 -> variably massive cysts
the only appear in the 4-5th decades -> HTN, hematuria, pain, polyuria, proteinuria and
eventual renal failure -> associated with Berry aneurysms, polycystic liver disease, cystic
spleen/pancreas/lung, colonic diverticulosis, mitral valve prolapse
- ARPKD = PKHD gene (fibrocystin) mutation on chromosome 6 -> bilateral multiple small
cysts (cuboidal cells) occurring in utero or childhood-> associated with Patau, Potters
sequence, hepatic fibrosis, portal HTN
- Multicystic renal dysplasia = abnormal differentiation of metanephric bud -> enlarged
kidney with multiple small cysts, primitive ducts, islands of cartilage
- Medullary sponge kidney = cystic dilatations of medullary collecting ducts in adults ->
risk of nephrolithiasis, infections, hematuria
- Familial juvenile nephronophthisis/uremic medullary cystic disease = shrunken kidneys
(cortical atrophy + interstitial fibrosis) with corticomedullary cysts -> renal failure,
polyuria, tubular acidosis, anemia
- Acquired cysts = associated with renal dialysis and renal cell carcinoma -> cysts
containing calcium oxalate crystals
Acute kidney injury = can be due to glomerular/interstitial/vascular/tubular injury ->
oliguria/anuria, azotemia
UTIs = can be pyelonephritis (upper UTI in kidney) or cystitis (lower UTI in bladder)
Pharmacology